Drugs / Autologous fibroblasts
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01858753 | May 2013 → May 2016 | — | Castle Creek Biosciences, LLC. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous fibroblasts | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01858753 ↗ |
| Modality | Cell therapy | “Autologous fibroblasts grown in culture from skin biopsy taken from patient. The cells will be injected into the scars to be treated.” NCT01858753 ↗ |